Microfluidics International Corporation Announces Third Quarter 2009 Financi...(ast five fiscal years; the timing and si...)

Date:11/2/2009

ast five fiscal years; the timing and size of customer orders for our products; the adoption, timing and performance of new technology and products developed by us; changes and advances in technology that may make our products obsolete or reduce demand for our products; our ability to protect and maintain the confidentiality of our intellectual property; our ability to retain key employees and our reliance on a new management team; changes in governmental rules and regulations, including those regulating the exportation of goods; and general economic and business conditions and the financial crisis, including those adversely effecting the pharmaceutical and biotechnology industries. For a more detailed discussion of risks and uncertainties which could cause actual results to differ from those contained in our forward-looking statements, see Item 1A, "Risk Factors" of our most recently filed Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 and our other periodic reports filed with the SEC. You should not place undue reliance on our forward-looking statements, which speak only as of the date they are made. We are providing this information as of this date, and we do not undertake to update the information included in this press release, whether as a result of new information, future events or otherwise.

                         --Financial Charts to Follow--


                MICROFLUIDICS INTERNATIONAL CORPORATION
                  Condensed Consolidated Balance Sheets
       (Unaudited - in thousands, except share and per share amounts)


                                                  September 30, December 31,
                                                        2009         2008
                                                        ----         ----
       ASSETS
       Current assets:
         Cash and cash equivalents                    $1,694       $1,895
         Accounts receivable, net of allowance of
          $44 at both
'/>"/>
SOURCE  Microfluidics International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 
Related biology technology :

1. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
2. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
3. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
4. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
5. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
6. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
7. GEN Reports on Growing Reliance on Microfluidics Technology
8. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
9. eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations
10. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009 
11. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China